Physician profile
Phillip C Wu
NPI 1962481598
$7,634.88
in general payments reported to CMS, 2019-2025
31 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $806 · 2021: $1,081 · 2022: $1,275 · 2023: $1,718 · 2024: $1,067 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,038 · Entertainment: $28.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,037.84 |
| Entertainment | $28.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,267.55 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Alcon Vision LLC | $676.71 | 2019-2025 | Rocklatan, Centurion, Clareon |
| Allergan, INC. | $667.25 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $610.66 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $530.27 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Biotissue Holdings INC. | $512.98 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $484.55 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $437.18 | 2020-2023 | Tobradex St |
| New World Medical,INC. | $310.09 | 2023 | |
| Sight Sciences, INC. | $270.26 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument, Tearcare System |
| Mallinckrodt Hospital Products INC. | $215.83 | 2022-2025 | Acthar |
| Kala Pharmaceuticals, INC. | $205.36 | 2019-2022 | |
| Harrow Eye, LLC | $165.43 | 2024-2025 | Vevye |
| Thea Pharma INC. | $160.24 | 2022-2024 | Iyuzeh |
| Ocular Therapeutix, INC. | $154.44 | 2023-2025 | Dextenza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $148.42 | 2019-2025 | Cequa |
| Aerie Pharmaceuticals, INC. | $136.50 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $117.24 | 2024-2025 | Xdemvy |
| Amgen INC. | $105.68 | 2024-2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $90.85 | 2023-2024 | Tecnis Iol, Tecnis Simplicity |
| Dompe US, INC. | $75.36 | 2024-2025 | Oxervate |
| Akorn Operating Company LLC | $42.92 | 2021 | |
| Notal Vision, INC. | $40.00 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Rayner Intraocular Lenses Limited | $30.56 | 2024 | Rayone Aspheric, Omidria, Rayone Emv |
| Oyster Point Pharma, INC. | $28.91 | 2023 | Tyrvaya |
| Optos, INC. | $28.47 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Rxsight INC | $27.78 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Apellis Pharmaceuticals, INC. | $26.41 | 2025 | Syfovre |
| Merz Pharmaceuticals, LLC | $23.79 | 2024 | Xeomin |
| Quidel Corporation | $4.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.